Atopic dermatitis patients | OPTH - Dove Medical Press

We describe clinical findings and treatment of dupilumab-related ocular complications.

Introduction Since 2017, dupilumab has been approved by the Food and Drug Administration (FDA) to treat adults with moderate-to-severe atopic dermatitis (AD) that is refractory to topical therapies.… [+27649 chars]

full article...